PRMT5 mediates cancer stemness and acquired drug resistance in EGFR-mutant non-small cell lung cancer

○Yoshinori Abe, Takumi Sano, Nobuyuki Tanaka

[1P-0133] PRMT5 mediates cancer stemness and acquired drug resistance in EGFR-mutant non-small cell lung cancer

○Yoshinori Abe¹, Takumi Sano¹, Nobuyuki Tanaka¹ (1.Dept. Mol. Oncl., Inst. Adv. Med. Sci., Nippon Med. Sch.)

lung cancer, cancer stem cell, PRMT5

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

The 43rd Annual Meeting of the Molecular Biology Society of Japan

[1P-0133] PRMT5 mediates cancer stemness and acquired drug resistance in EGFR-mutant non-small cell lung cancer

Password